In addition to directly killing tumor cells driven by NK cell activating receptors, ADCC mediated by CD16 engagement on NK cells is a key mechanism of action of NK cell-mediated tumor cell killing, especially for tumor targeting antibodies. This evidence concerns the gene FCGR3A and neoplasm.